Mentions
Extended reach
Total likes
Video views
AI synopsis
Many posts express enthusiasm for the progress made in RSV vaccination, with phrases like 'potential,' 'future possibilities,' and references to recommendations from CDC. The tone is optimistic and forward-looking, emphasizing the importance of vaccination efforts and ongoing research. This suggests a generally positive perception of the publication's impact, though with a focus on future implications rather than immediate change.
Most discussions support the idea that RSV vaccines are promising and necessary, with some emphasizing the importance of recent recommendations and developments.
Posts exhibit high curiosity, referencing future possibilities like universal vaccines and mentioning ongoing research efforts, reflecting a keen interest in the topic.
The majority of posts briefly summarize findings or mention forthcoming vaccines, indicating surface-level engagement rather than deep critical analysis.
While the discussion highlights the significance of RSV vaccination for public health, most posts are more informational than suggestive of sudden or transformative impact.
Viewpoint discusses recommendations from @CDCgov for newly licensed immunizations for RSV in infants, children with high-risk conditions, and older adults. https://t.co/HtY7bmfFcW https://t.co/HGZqJ9hKRc
Quizás en un futuro próximo podremos administrar a nuestros ancianos una sola inyección de una vacuna triple vírica que les proteja frente a la gripe, a la COVID y al Virus Respiratorio Sincitial. https://t.co/HebjeYC1OH
A new JAMA Viewpoint by CDC authors discusses the real-world effectiveness of immunizations for RSV. Watch this video short and read the full article: https://t.co/JW7sZnsFfV https://t.co/4J3GSKBDgQ
Viewpoint discusses recommendations from @CDCgov for newly licensed immunizations for RSV in infants, children with high-risk conditions, and older adults. https://t.co/QR3aHTHUpq
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus | Vaccination | JAMA https://t.co/WHk7BsRmT1
#ICYMI: Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus (#RSV) https://t.co/SgwS3gMAoK via @JAMANetwork #GetVaccinated #PreventRSV https://t.co/4Jd55Uv9OH
Respiratory syncytial virus RSV is a common infection that may cause severe illness in infants, young children, and older adults. This video discusses current therapies and the importance of assessing vaccine…
A recent JAMA Viewpoint by CDC authors discusses how well current vaccines for Respiratory Syncytial Virus work outside clinical trials, focusing on diverse populations and real-world environments to guide public health…
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus | Vaccination | JAMA | JAMA Network https://t.co/t1sr6N1xaI
RT @JAMA_current: Viewpoint discusses recommendations from @CDCgov for newly licensed immunizations for RSV in infants, children with high-…
RT @JAMA_current: Viewpoint discusses recommendations from @CDCgov for newly licensed immunizations for RSV in infants, children with high-…
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus https://t.co/mbCu6NcQCm
Viewpoint discusses recommendations from @CDCgov for newly licensed immunizations for RSV in infants, children with high-risk conditions, and older adults. https://t.co/HtY7bmfFcW https://t.co/HGZqJ9hKRc
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus https://t.co/F4v4dTomPn
RT @juanelosag: Quizás en un futuro próximo podremos administrar a nuestros ancianos una sola inyección de una vacuna triple vírica que les…
RT @NFIDVaccines: #ICYMI: Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus (#RSV) https://t.co/SgwS…
RT @juanelosag: Quizás en un futuro próximo podremos administrar a nuestros ancianos una sola inyección de una vacuna triple vírica que les…
RT @NFIDVaccines: #ICYMI: Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus (#RSV) https://t.co/SgwS…
RT @juanelosag: Quizás en un futuro próximo podremos administrar a nuestros ancianos una sola inyección de una vacuna triple vírica que les…
RT @juanelosag: Quizás en un futuro próximo podremos administrar a nuestros ancianos una sola inyección de una vacuna triple vírica que les…
RT @juanelosag: Quizás en un futuro próximo podremos administrar a nuestros ancianos una sola inyección de una vacuna triple vírica que les…
Quizás en un futuro próximo podremos administrar a nuestros ancianos una sola inyección de una vacuna triple vírica que les proteja frente a la gripe, a la COVID y al Virus Respiratorio Sincitial. https://t.co/HebjeYC1OH
#ICYMI: Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus (#RSV) https://t.co/SgwS3gMAoK via @JAMANetwork #GetVaccinated #PreventRSV https://t.co/4Jd55Uv9OH
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus https://t.co/eIVhf467A7
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus https://t.co/mXHLBJB5wZ
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus | Vaccination | JAMA | JAMA Network https://t.co/IfIiQAE6GH
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus | Vaccination | JAMA https://t.co/WHk7BsRmT1
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus #science #publication #research #publications https://t.co/VPL9Y8yTLc
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus https://t.co/INnQG4F5Ti
Global burden of RSV infection among young children and adults is significant. One of the effective preventive interventions to prevent severe RSV disease is the use of RSV vaccine. Potential and viable RSV vaccine candidates are in the pipeline.
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus jamanetwork.com/journals/jam...
Viewpoint discusses recommendations from @CDCgov for newly licensed immunizations for RSV in infants, children with high-risk conditions, and older adults. https://t.co/QR3aHTHUpq
RT @JAMA_current: A new JAMA Viewpoint by CDC authors discusses the real-world effectiveness of immunizations for RSV. Watch this video s…
RT @JAMA_current: A new JAMA Viewpoint by CDC authors discusses the real-world effectiveness of immunizations for RSV. Watch this video s…
A new JAMA Viewpoint by CDC authors discusses the real-world effectiveness of immunizations for RSV. Watch this video short and read the full article: https://t.co/JW7sZnsFfV https://t.co/4J3GSKBDgQ
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus https://t.co/gknzNqNhtu